INGN Inogen Inc

Price (delayed)

$30.44

Market cap

$691.72M

P/E Ratio

60.88

Dividend/share

N/A

EPS

$0.5

Enterprise value

$477.78M

Inogen is a medical technology company offering innovative respiratory products for use in the homecare setting. Inogen primarily develops, manufactures, and markets innovative portable oxygen concentrators used to deliver supplemental ...

Highlights
Inogen's gross profit has increased by 25% YoY and by 9% from the previous quarter
The revenue has increased by 13% year-on-year and by 6% since the previous quarter
The debt has soared by 164% year-on-year but it has declined by 2.9% since the previous quarter
The quick ratio has contracted by 4.3% YoY

Key stats

What are the main financial stats of INGN
Market
Shares outstanding
22.72M
Market cap
$691.72M
Enterprise value
$477.78M
Valuations
Price to earnings (P/E)
60.88
Price to book (P/B)
1.76
Price to sales (P/S)
1.94
EV/EBIT
46.19
EV/EBITDA
15.35
EV/Sales
1.34
Earnings
Revenue
$355.58M
EBIT
$10.34M
EBITDA
$31.13M
Free cash flow
$9.43M
Per share
EPS
$0.5
Free cash flow per share
$0.42
Book value per share
$17.29
Revenue per share
$15.72
TBVPS
$18.46
Balance sheet
Total assets
$512.86M
Total liabilities
$121.94M
Debt
$27.64M
Equity
$390.92M
Working capital
$275.9M
Liquidity
Debt to equity
0.07
Current ratio
5.6
Quick ratio
4.64
Net debt/EBITDA
-6.87
Margins
EBITDA margin
8.8%
Gross margin
48.4%
Net margin
3.2%
Operating margin
2.9%
Efficiency
Return on assets
2.3%
Return on equity
3.1%
Return on invested capital
8.4%
Return on capital employed
2.3%
Return on sales
2.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

INGN stock price

How has the Inogen stock price performed over time
Intraday
0.07%
1 week
-3.27%
1 month
-7.36%
1 year
-33.22%
YTD
-10.47%
QTD
-10.47%

Financial performance

How have Inogen's revenue and profit performed over time
Revenue
$355.58M
Gross profit
$171.95M
Operating income
$10.39M
Net income
$11.42M
Gross margin
48.4%
Net margin
3.2%
INGN's operating income has surged by 188% year-on-year
The operating margin has soared by 176% YoY
Inogen's gross profit has increased by 25% YoY and by 9% from the previous quarter
The revenue has increased by 13% year-on-year and by 6% since the previous quarter

Growth

What is Inogen's growth rate over time

Valuation

What is Inogen stock price valuation
P/E
60.88
P/B
1.76
P/S
1.94
EV/EBIT
46.19
EV/EBITDA
15.35
EV/Sales
1.34
INGN's P/B is 74% below its 5-year quarterly average of 6.7 and 43% below its last 4 quarters average of 3.1
The equity rose by 11% year-on-year and by 5% since the previous quarter
The stock's price to sales (P/S) is 69% less than its 5-year quarterly average of 6.2 and 45% less than its last 4 quarters average of 3.5
The revenue has increased by 13% year-on-year and by 6% since the previous quarter

Efficiency

How efficient is Inogen business performance

Dividends

What is INGN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INGN.

Financial health

How did Inogen financials performed over time
The total liabilities has grown by 13% YoY but it has contracted by 4.2% from the previous quarter
INGN's total assets is up by 11% year-on-year and by 2.9% since the previous quarter
The debt is 93% smaller than the equity
The debt has soared by 164% year-on-year but it has declined by 2.9% since the previous quarter
The debt to equity has soared by 133% YoY but it has decreased by 13% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.